Therapeutic Asset Ratings
236 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
azd0754
Hepatocellular Carcinoma
AstraZeneca
D
(28)
BLOOD, WHOLE
Hepatocellular Carcinoma
University Hospital, Angers
N/A
D
(28)
Gadobutrol
Hepatocellular Carcinoma
M.D. Anderson Cancer Center
N/A
D
(28)
Hepatect Cp 50 I.E./Ml Infusion
Hepatocellular Carcinoma
Medical University of Graz
N/A
D
(28)
MEGESTROL ACETATE IMPURITY B
Hepatocellular Carcinoma
Changchun GeneScience Pharmaceutical Co., Ltd.
D
(28)
Nano-Crystalline Megestrol Acetate Suspension
Hepatocellular Carcinoma
Changchun GeneScience Pharmaceutical Co., Ltd.
D
(28)
PERFLUBUTANE
Hepatocellular Carcinoma
Institute of Liver and Biliary Sciences, India
N/A
D
(28)
ROPIVACAINE
Hepatocellular Carcinoma
Sixth Affiliated Hospital, Sun Yat-sen University
N/A
D
(28)
Vic-1911
Hepatocellular Carcinoma
RenJi Hospital
N/A
D
(28)
Gkl-006
Hepatocellular Carcinoma
Beijing Gene Key Life Technology Co., Ltd
P2
NR
(0)
Compound Cantharides
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital
P2/3
NR
(0)
Showing 226 to 236 of 236 assets
Previous
Page 10 of 10
Next
